External shock waves therapy in dystonia: preliminary results

Area of Science:

• Neurology
• Physical Medicine and Rehabilitation

Background:

• Extracorporeal shock wave therapy (ESWT) is recognized for reducing hypertonia in upper motor neuron syndrome.
• The efficacy of ESWT in managing dystonia, a condition characterized by involuntary muscle contractions, has not been extensively studied.

Purpose of the Study:

• To investigate the potential therapeutic benefits of ESWT in patients diagnosed with dystonia.
• To assess the safety and effectiveness of ESWT as a treatment modality for different forms of dystonia.

Main Methods:

• A pilot study involving six patients: three with secondary dystonia and three with idiopathic writer's cramp.
• ESWT was administered over four weekly sessions to affected hand and forearm muscles using an electromagnetic lithotripter.
• Clinical outcomes were assessed using standardized scales, including the Unified Dystonia Rating Scale and the Arm Dystonia Disability Scale.

Main Results:

• Patients with secondary dystonia experienced marked improvement in symptoms lasting at least one month post-treatment.
• ESWT demonstrated less consistent efficacy in writer's cramp patients, with two out of three showing improvement.
• No adverse effects were reported during or after the ESWT sessions, indicating a favorable safety profile.

Conclusions:

• ESWT appears to be a potentially effective and safe treatment option for upper limb dystonia, especially secondary forms.
• Further investigation through larger, randomized controlled trials is warranted to validate these preliminary findings and establish ESWT's role in dystonia management.